Protection of Hematopoietic Progenitor Cells from Chemotherapy Toxicity by Transfer of Drug Resistance Genes

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/978-3-662-03577-1_8
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Stable in vivo gene transduction via a novel adenoviral/retroviral chimeric vector

  1997cited by this paper
• A gene transfer strategy for making bone marrow cells resistant to trimetrexate.

  1996cited by this paper
• Cationic facial amphiphiles: a promising class of transfection agents.

  1996cited by this paper
• Resistance to cytosine arabinoside by retrovirally mediated gene transfer of human cytidine deaminase into murine fibroblast and hematopoietic cells.

  1996cited by this paper
• Gene therapy--the challenge for the future.

  1996cited by this paper
• Human CD34+ hematopoietic progenitors have low, cytokine-unresponsive O6-alkylguanine-DNA alkyltransferase and are sensitive to O6-benzylguanine plus BCNU.

  1996cited by this paper
• Protection of mammalian cells against chloroethylating agent toxicity by an O6-benzylguanine-resistant mutant of human O6-alkylguanine-DNA alkyltransferase.

  1996cited by this paper
• In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector

  1996cited by this paper
• Overexpression of the human aldehyde dehydrogenase class I results in increased resistance to 4-hydroperoxycyclophosphamide.

  1996cited by this paper
• Flt3 ligand induces proliferation of quiescent human bone marrow CD34+CD38- cells and maintains progenitor cells in vitro.

  1996cited by this paper
• Induction of cyclophosphamide-resistance by aldehyde-dehydrogenase gene transfer.

  1996cited by this paper
• Long-term protection of hematopoiesis against the cytotoxic effects of multiple doses of nitrosourea by retrovirus-mediated expression of human O6-alkylguanine-DNA-alkyltransferase.

  1996cited by this paper
• Forced expression of cytidine deaminase confers resistance to cytosine arabinoside and gemcitabine.

  1996cited by this paper
• Active site-directed double mutants of dihydrofolate reductase.

  1996cited by this paper
• Gene Therapy in Peripheral Blood Lymphocytes and Bone Marrow for ADA− Immunodeficient Patients

  1995cited by this paper
• Protection of mice from lethal doses of methotrexate by transplantation with transgenic marrow expressing drug-resistant dihydrofolate reductase activity.

  1995cited by this paper
• Ex vivo expansion and selection of human CD34+ peripheral blood progenitor cells after introduction of a mutated dihydrofolate reductase cDNA via retroviral gene transfer.

  1995cited by this paper
• Hematopoietic reconstruction: new approaches.

  1995cited by this paper
• Retrovirus-mediated expression of a DNA repair protein in bone marrow protects hematopoietic cells from nitrosourea-induced toxicity in vitro and in vivo.

  1995cited by this paper
• Expression of retroviral vectors containing the human multidrug resistance 1 cDNA in hematopoietic cells of transplanted mice.

  1995cited by this paper
• Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation.

  1995cited by this paper
• Preselection of transduced murine hematopoietic stem cell populations leads to increased long-term stability and expression of the human multiple drug resistance gene.

  1995cited by this paper
• Retroviral transduction and expression of the human alkyltransferase cDNA provides nitrosourea resistance to hematopoietic cells.

  1995cited by this paper
• Long-term protection of recipient mice from lethal doses of methotrexate by marrow infected with a double-copy vector retrovirus containing a mutant dihydrofolate reductase.

  1994cited by this paper
• Use of Safety-Modified Retroviruses to Introduce Chemotherapy Resistance Sequences into Normal Hematopoietic Cells for Chemoprotection During the Therapy of Ovarian Cancer: A Pilot Trial. M.D. Anderson Cancer Center, Houston, Texas

  1994cited by this paper
• Retroviral Mediated Transfer of the Human Multidrug Resistance Gene (MDR-1) into Hematopoietic Stem Cells During Autologous Transplantation after Intensive Chemotherapy for Metastatic Breast Cancer. National Institutes of Health, Bethesda, Maryland

  1994cited by this paper
• Detoxification of cyclophosphamide by human aldehyde dehydrogenase isozymes.

  1994cited by this paper
• Transfection of a nonactive site mutant murine DHFR cDNA (the tryptophan 15 mutant) into Chinese hamster ovary and mouse marrow progenitor cells imparts MTX resistance in vitro.

  1994cited by this paper
• Ex vivo expansion of cord blood-derived stem cells and progenitors.

  1994cited by this paper
• Transfection with a cDNA encoding a Ser31 or Ser34 mutant human dihydrofolate reductase into Chinese hamster ovary and mouse marrow progenitor cells confers methotrexate resistance.

  1994cited by this paper
• Intrinsic cellular resistance to oxazaphosphorines exhibited by a human colon carcinoma cell line expressing relatively large amounts of a class-3 aldehyde dehydrogenase.

  1994cited by this paper
• Gene therapy utilizing drug resistance genes: A review

  1994cited by this paper
• Drug-selected coexpression of human glucocerebrosidase and P-glycoprotein using a bicistronic vector.

  1994cited by this paper
• Identification of a methylcholanthrene-induced aldehyde dehydrogenase in a human breast adenocarcinoma cell line exhibiting oxazaphosphorine-specific acquired resistance.

  1994cited by this paper
• Intensive therapy with cyclophosphamide, carmustine, etoposide +/- cisplatin, and autologous bone marrow transplantation for Hodgkin's disease in first relapse after combination chemotherapy.

  1994cited by this paper
• Transfer and expression of the human multiple drug resistance gene in human CD34+ cells.

  1994cited by this paper
• Clinical Protocol: Human MDR Gene Transfer in Patients with Advanced Cancer.

  1994cited by this paper
• Development of a retroviral construct containing a human mutated dihydrofolate reductase cDNA for hematopoietic stem cell transduction

  1994cited by this paper
• Transfection with a bcl-2 expression vector protects transplanted bone marrow from chemotherapy-induced myelosuppression.

  1994cited by this paper
• Retrovirus-mediated gene transfer of rat glutathione S-transferase Yc confers alkylating drug resistance in NIH 3T3 mouse fibroblasts.

  1994cited by this paper
• Mutations in human O6-alkylguanine-DNA alkyltransferase imparting resistance to O6-benzylguanine.

  1994cited by this paper
• Serial transplantation shows that early hematopoietic precursor cells are transduced by MDR-1 retroviral vector in a mouse gene therapy model.

  1994cited by this paper
• Bcl2 inhibits apoptosis associated with terminal differentiation of HL-60 myeloid leukemia cells.

  1994cited by this paper
• Molecular controls of apoptosis: differentiation/growth arrest primary response genes, proto-oncogenes, and tumor suppressor genes as positive & negative modulators.

  1994cited by this paper
• Human cytidine deaminase: purification of enzyme, cloning, and expression of its complementary DNA.

  1994cited by this paper
• The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin's disease. A single-center eight-year study of 155 patients.

  1993cited by this paper
• Bcl-2 functions in an antioxidant pathway to prevent apoptosis.

  1993cited by this paper
• Overexpression of mitochondrial manganese superoxide dismutase promotes the survival of tumor cells exposed to interleukin‐1, tumor necrosis factor, selected anticancer drugs, and ionizing radiation

  1993cited by this paper
• A single amino acid change in human O6-alkylguanine-DNA alkyltransferase decreasing sensitivity to inactivation by O6-benzylguanine.

  1993cited by this paper
• High dose chemotherapy followed by autologous hematopoietic rescue in Hodgkin's disease: long-term follow-up in 128 patients.

  1993cited by this paper
• High-dose chemotherapy and autologous bone marrow transplantation for patients with poor prognosis nonseminomatous germ cell tumours.

  1993cited by this paper
• Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair.

  1993cited by this paper
• Enhanced transcription of the cytosolic ALDH gene in cyclophosphamide resistant human carcinoma cells.

  1993cited by this paper
• Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death.

  1993cited by this paper
• Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients.

  1993cited by this paper
• Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line.

  1993cited by this paper
• Cloning and expression of the full-length cDNAS encoding human liver class 1 and class 2 aldehyde dehydrogenase.

  1993cited by this paper
• bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death.

  1993cited by this paper
• Glutathione S-transferases: biomedical applications.

  1993cited by this paper
• Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells.

  1993cited by this paper
• Dual-target inhibition of HIV-1 in vitro by means of an adeno-associated virus antisense vector.

  1992cited by this paper
• Construction of a dominant selectable marker using a novel dihydrofolate reductase.

  1992cited by this paper
• bcl-2 gene transfer increases relative resistance of S49.1 and WEHI7.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs.

  1992cited by this paper
• Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype.

  1992cited by this paper
• Human stomach aldehyde dehydrogenase cDNA and genomic cloning, primary structure, and expression in Escherichia coli.

  1992cited by this paper
• Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1.

  1992cited by this paper
• Multidrug resistance in human cancer.

  1992cited by this paper
• High-dose chemotheraphy supported with autologous bone marrow transplantation (ABMT) in germ cell tumors: A phase two study

  1992cited by this paper
• Stromal support enhances cell-free retroviral vector transduction of human bone marrow long-term culture-initiating cells.

  1992cited by this paper
• Transfer and expression of the human multiple drug resistance gene into live mice.

  1992cited by this paper
• Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes.

  1992cited by this paper
• Transfer and expression of the human multidrug resistance gene in mouse erythroleukemia cells

  1992cited by this paper
• Survival and retrovirus infection of murine hematopoietic stem cells in vitro: effects of 5-FU and method of infection.

  1991cited by this paper
• Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells.

  1991cited by this paper
• Retroviral gene transfer of human adenosine deaminase in murine hematopoietic cells: effect of selectable marker sequences on long-term expression.

  1991cited by this paper
• Transfection and expression of human O6-methylguanine-DNA methyltransferase (MGMT) cDNA in Chinese hamster cells: the role of MGMT in protection against the genotoxic effects of alkylating agents.

  1991cited by this paper
• Isolation and structural characterization of a cDNA clone encoding the human DNA repair protein for O6-alkylguanine

  1990cited by this paper
• Expression of human adenosine deaminase in mice reconstituted with retrovirus-transduced hematopoietic stem cells.

  1990cited by this paper
• Site-specific integration by adeno-associated virus.

  1990cited by this paper
• Expression of a human complementary DNA for the multidrug resistance gene in murine hematopoietic precursor cells with the use of retroviral gene transfer.

  1990cited by this paper
• Expression of human adenosine deaminase in mice after transplantation of genetically-modified bone marrow.

  1990cited by this paper
• Serial transplantation of methotrexate-resistant bone marrow: protection of murine recipients from drug toxicity by progeny of transduced stem cells

  1990cited by this paper
• Identification and characterization of a mutation in the dihydrofolate reductase gene from the methotrexate-resistant Chinese hamster ovary cell line Pro-3 MtxRIII.

  1990cited by this paper
• Isolation and characterization of a variant dihydrofolate reductase cDNA from methotrexate-resistant murine L5178Y cells.

  1990cited by this paper
• Expression of human glucocerebrosidase in murine long-term bone marrow cultures after retroviral vector-mediated transfer.

  1990cited by this paper
• Depletion of mammalian O6-alkylguanine-DNA alkyltransferase activity by O6-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agents.

  1990cited by this paper
• Direct demonstration of elevated aldehyde dehydrogenase in human hematopoietic progenitor cells

  1990cited by this paper
• Mammalian O6-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents.

  1990cited by this paper
• Multidrug resistance in cancer.

  1989cited by this paper
• Increase in nitrosourea resistance in mammalian cells by retrovirally mediated gene transfer of bacterial O6-alkylguanine-DNA alkyltransferase.

  1989cited by this paper
• Inherent resistance of human squamous carcinoma cell lines to methotrexate as a result of decreased polyglutamylation of this drug.

  1989cited by this paper
• Probing the role of two hydrophobic active site residues in the human dihydrofolate reductase by site-directed mutagenesis.

  1989cited by this paper
• Regulation of bcl-2 gene expression in lymphoid cell lines containing normal #18 or t(14;18) chromosomes.

  1989cited by this paper
• Combination of interleukins 3 and 6 preserves stem cell function in culture and enhances retrovirus-mediated gene transfer into hematopoietic stem cells.

  1989cited by this paper
• The biochemistry of P-glycoprotein-mediated multidrug resistance.

  1989cited by this paper
• Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor.

  1989cited by this paper
• P-glycoprotein and multidrug resistance in cancer chemotherapy.

  1989cited by this paper
• Effects of hemopoietic growth factors on stem cells in vitro.

  1989cited by this paper
• Expression of a human multidrug resistance cDNA (MDR1) in the bone marrow of transgenic mice: resistance to daunomycin-induced leukopenia

  1989cited by this paper
• Transfection of murine multi-potent haemopoietic stem cells with an E. coli DNA alkyltransferase gene confers resistance to the toxic effects of alkylating agents.

  1988cited by this paper

• No citing papers are available for this paper.